COMMUNIQUÉ DE PRESSE
News
-
-
-
COMMUNIQUÉ DE PRESSE
TruLab Integration to Florence Streamlines Biospecimen Data Management for Clinical Sites
TruLab and Florence Healthcare announce a technology partnership to provide a single solution for biospecimen and protocol data storage. The integrated platform will reduce lab queries, eliminate manual data entry, and provide centralized monitoring of protocol exceptions -
COMMUNIQUÉ DE PRESSE
TuHURA Biosciences, Inc. Appoints Dennis Yamashita, Ph.D., as Chief Scientific Officer and Head of Discovery Research and Early Development
TuHURA Biosciences, Inc. appoints Dr. Dennis Yamashita as Chief Scientific Officer and Head of Discovery Research and Early Development to advance novel personalized cancer vaccines and bi-functional antibody drug conjugates. Dr. Yamashita brings over 30 years of experience in R&D drug discovery and development -
COMMUNIQUÉ DE PRESSE
Cloud DX Receives $770,000 Order for New Technology Devices and Services
Cloud DX (TSXV:CDX)(OTCQB:CDXFF) receives a purchase order for up to 300 Vitaliti™ Continuous Vital Sign Monitor Systems and related software valued at approximately $770,000 CAD. The order, including a 50% deposit, is expected to be delivered by the end of Q2 2024 for a groundbreaking multi-site academic study of post-surgical patients -
-
-
COMMUNIQUÉ DE PRESSE
Moody's upgrades OLB's ratings, reflecting strengthened financial profile and outlook
Moody's upgrades OLB's ratings to Baa1 from Baa2, reflecting strengthened financial profile and outlook. OLB achieves upgrade of its long-term deposit, senior unsecured, and long-term issuer ratings by Moody's to Baa1 from Baa2. The stable outlook on OLB's ratings reflects Moody's expectation of continued fundamental strength -
COMMUNIQUÉ DE PRESSE
Canada’s Building Trades Unions introduces Building It Green - Canada's Most Comprehensive Climate-focused Construction Curriculum
Canada's Building Trades Unions (CBTU) launches Building It Green, a climate-focused construction education program for tradespeople. The program is funded by the Government of Canada and aims to support the industry's transition to a sustainable future -
COMMUNIQUÉ DE PRESSE
Protenus is Awarded Top-Performing Solutions Vendor in Two Segments for Second Consecutive Year Based on 2024 Best in KLAS Report
Protenus, a healthcare compliance analytics platform, achieves highest score for patient privacy monitoring and drug diversion surveillance solutions for the second year in a row, as reported by 2024 Best in KLAS: Software & Services. Protenus' AI-driven solutions help healthcare organizations nationwide to proactively identify and prevent privacy data breaches and drug diversion, reducing manual tasks and focusing on better risk-reduction outcomes
